May 29 (Reuters) - Zymeworks Inc ZYME.TO :
* ZYMEWORKS EARNS MILESTONE PAYMENT IN MERCK COLLABORATION
* ZYMEWORKS - UNDER TERMS, CO GRANTED MERCK WORLDWIDE, ROYALTY-BEARING LICENSE TO RESEARCH, DEVELOP & COMMERCIALIZE CERTAIN BISPECIFIC THERAPEUTIC CANDIDATES
* ZYMEWORKS - UNDER TERMS, CO IS ELIGIBLE TO RECEIVE ADDITIONAL DEVELOPMENT & COMMERCIAL MILESTONE PAYMENTS AS WELL AS TIERED ROYALTIES ON PRODUCT SALES
* ZYMEWORKS INC - WILL RECEIVE US$2.0 MILLION IN CONNECTION WITH MERCK'S COMPLETION OF A LATE-STAGE PRECLINICAL STUDY FOR A BISPECIFIC ANTIBODY CANDIDATE